关于加拿大的慢性失眠管理的德尔菲共识建议
Charles M Morin1, Atul Khullar2, Rebecca Robillard3
1École de Psychologie and Centre de recherche CERVO/Brain Research Center, Université Laval, QC, Canada.
Sleep medicine
|October 31, 2024
概括
由于缺乏实践指南,加拿大专家为慢性失眠管理制定了共识建议. 这些指南强调对失眠的认知行为疗法 (CBT-I) 和最新的药物治疗.
科学领域:
- 睡眠医学 睡眠医学
- 临床实践指南 临床实践指南
背景情况:
- 目前加拿大对失眠管理的实践指南缺乏,这给医疗保健提供者带来了挑战.
- 这就需要为慢性失眠治疗制定专家共识建议.
研究的目的:
- 建立专家共识建议,用于加拿大慢性失眠的管理.
- 为治疗失眠的医疗保健提供者提供基于证据的指导.
主要方法:
- 采用了德尔菲方法,涉及来自加拿大的16名多学科睡眠医学专家.
- 共识被定义为投票参与者之间至少75%的同意.
- 用GRADE评级系统来评估支持证据的质量.
主要成果:
- 专家小组在慢性失眠管理方面达成了37项建议的共识.
- 关键建议包括提高对失眠认知行为疗法 (CBT-I) 的认识,能力和获取.
- 专家们还同意整合新批准的药物治疗,减少自我治疗或证据有限的药物.
结论:
- 开发的共识建议解决了加拿大改善失眠护理的需要.
- 重点是提高CBT-I可访问性和合理使用药物治疗.
- 还建议减少对自我治疗和低益处药物的依赖.
相关概念视频
Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231
Insomnia
79
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
79
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
Insufficient Sleep and Sleep Deprivation
134
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
134
CNS Depressants: Barbiturates and Benzodiazepines
227
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
227
Sedatives and Hypnotics: Overview
281
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
281


